Rick E. Winningham - 14 Dec 2022 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
14 Dec 2022
Net transactions value
-$559,500
Form type
4
Filing time
16 Dec 2022, 18:36:34 UTC
Previous filing
22 Nov 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Gift -9,000 -0.64% 1,400,797 13 Dec 2022 Direct F1
transaction TBPH Ordinary Shares Sale $559,500 -50,000 -3.6% $11.19 1,350,797 14 Dec 2022 Direct F2
holding TBPH Ordinary Shares 92,567 14 Dec 2022 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bona Fide Gift. No compensation was given to the donor for the gifting of shares.
F2 This transaction was executed in multiple trades at prices from $11.17 to $11.235 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.